不确定的潜力和神经退行性疾病的风险的克隆性血液形成
Xinyuan Liu1, Huiwen Xue2,3, Karin Wirdefeldt4
1Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), State Key Laboratory of Genetic Engineering, Center for Evolutionary Biology, School of Life Sciences, Fudan University, Guangzhou, China.
Journal of internal medicine
|July 29, 2024
概括
不确定潜力的克隆性血液形成 (CHIP) 与神经退行性疾病的更高风险有关,特别是血管类型和ALS. 这表明共享的潜在生物途径可能连接这些条件.
科学领域:
- 血液学 血液学 血液学
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 是一种血液细胞获得突变的情况,但其与神经退行性疾病的关联在很大程度上是未知的.
- 了解这种联系对于识别潜在的共同风险因素和疾病机制至关重要.
研究的目的:
- 研究不确定潜力的克隆性血液形成 (CHIP) 与发展神经退行性疾病的风险之间的关联.
- 分析CHIP患者神经退行性疾病的特定亚型和诊断风险.
主要方法:
- 一项基于社区的队列研究,利用英国生物库的数据.
- 考克斯回归分析用于估计CHIP和无CHIP患者的神经退行性疾病风险的危险比率 (HRs) 和95%置信区间 (CI).
主要成果:
- 患有CHIP的个体显示神经退行性疾病的总体风险增加 (HR 1.10).
- 血管神经退行性疾病 (HR 1.31) 和肌缩性侧面硬化症 (ALS) (HR 1.50) 的风险明显增加.
- 在CHIP中发生的特定突变 (DNMT3A,ASXL1,SRSF2) 与风险增加有关.
结论:
- 不确定潜力的克隆性血液形成 (CHIP) 与神经退行性疾病的风险增加有关,特别是血管类型和ALS.
- 这些发现表明,CHIP和神经退行性疾病背后可能存在共同的生物机制.
- 对这些共享途径的进一步研究可能会提供新的治疗点.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Production of Formed Elements
1.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.4K


